Shivani Kamat, MD
Show Description +
In this roundtable discussion from the Interventional Glaucoma Consortium (IGC) 2024, Shivani Kamat, MD, reviews the canaloplasty procedure, discusses the importance of early intervention in glaucoma treatment, and describes how she consults and educates patients about their treatment options. Importantly, she addresses the multi-modal mechanism of action of canaloplasty. which is designed to target and treat the trabecular meshwork, Schlemm’s canal and the collector channels.
Posted: 4/21/2025
Shivani Kamat, MD
In this roundtable discussion from the Interventional Glaucoma Consortium (IGC) 2024, Shivani Kamat, MD, reviews the canaloplasty procedure, discusses the importance of early intervention in glaucoma treatment, and describes how she consults and educates patients about their treatment options. Importantly, she addresses the multi-modal mechanism of action of canaloplasty. which is designed to target and treat the trabecular meshwork, Schlemm’s canal and the collector channels.
Posted: 4/21/2025
Combined Canaloplasty and Cataract Surgery: Considerations for Implementation and Adoption
The Opportunity in Canaloplasty
Restoring the Anatomy with Canaloplasty
Understanding the Mechanisms Associated With Canaloplasty
Case Review: Canaloplasty in a Case of Steroid-Induced Uncontrolled Ocular Hypertension
The Versatility of Standalone Canaloplasty
Targeting and Treating All Glaucoma Anatomy with Canaloplasty
Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 2
Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 1
About Nova Eye Medical
WE ARE NOVA EYE MEDICAL
With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.
Visit Us Online: nova-eye.com
Follow Nova Eye Medical
The Nova Eye iTrack™ Advance is indicated for fluid infusion or aspiration during surgery.
The Nova Eye iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.*
The Nova Eye iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma.
* The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma.